Table 5.
Number (%) of women with individual spot urine samples in the same tertile of exposure during pregnancy.a
| No. of samples in the same tertile | ΣDEHP metabolitesb | MBP | MBzP | MEP | BPA | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| None | 16 (21) | 18 (23) | 16 (21) | 16 (21) | 16 (18) | |||||
| 2 | 49 (64) | 39 (51) | 49 (64) | 48 (62) | 54 (59) | |||||
| 3 | 12 (16) | 20 (26) | 12 (16) | 13 (17) | 21 (23) | |||||
| aLimited to women with all three pregnancy urine samples (n = 77 for phthalate analysis; n = 91 for BPA analysis). bDEHP metabolites: mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethylhexyl) phthalate (MEHP). | ||||||||||